![William Hahne](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
William F.
Hahne worked as an Executive Director of Clinical Research at Eisai, Inc. from 1997 to 2002.
He then served as a Vice President of Medical at Vion Pharmaceuticals, Inc. After that, he held the position of VP of Clinical Development & Medical Affairs at Imunon, Inc. from 2006 to 2007.
Prior to that, he was a Vice President of Clinical Development at CuraGen Corp.
from 2003 to 2005.
He also worked as a Vice President of Clinical Development at CuraGen Corp.
and as a Vice President of Clinical Research at Bio-Path Holdings, Inc. Dr. Hahne completed his undergraduate degree at Grinnell College and obtained a doctorate degree from Cornell University.
Anciens postes connus de William Hahne
| Sociétés | Poste | Fin |
|---|---|---|
| IMUNON, INC. | Directeur Technique/Scientifique/R&D | 01/12/2007 |
CuraGen Corp.
 CuraGen Corp. Pharmaceuticals: MajorHealth Technology Develops protein, antibody and small molecule pharmaceutical products | Directeur Technique/Scientifique/R&D | 01/01/2005 |
Eisai, Inc.
 Eisai, Inc. Pharmaceuticals: MajorHealth Technology Manufacturers pharmaceutical products | Directeur Technique/Scientifique/R&D | 01/01/2002 |
| BIO-PATH HOLDINGS, INC. | Directeur Technique/Scientifique/R&D | - |
Vion Pharmaceuticals, Inc.
 Vion Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops small molecule anticancer compounds | Directeur Technique/Scientifique/R&D | - |
Formation de William Hahne
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
18
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Vion Pharmaceuticals, Inc.
Vion Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops small molecule anticancer compounds | Health Technology |
Imunon, Inc.
 Imunon, Inc. BiotechnologyHealth Technology Engages in the provision of oncology drug development services | Health Technology |
CuraGen Corp.
CuraGen Corp. Pharmaceuticals: MajorHealth Technology Develops protein, antibody and small molecule pharmaceutical products | Health Technology |
Bio-Path Holdings, Inc.
 Bio-Path Holdings, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company, which focuses on developing therapeutic products | Health Technology |
Eisai, Inc.
Eisai, Inc. Pharmaceuticals: MajorHealth Technology Manufacturers pharmaceutical products | Health Technology |
Grinnell College
 Grinnell College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
